#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Lymphatic malformation Synovial sarcoma recurrent Congenital megacolon Cardiac sarcoidosis Metachromatic leukodystrophy Biotinidase deficiency Haemophilia B without inhibitors Alport's syndrome Drug eruption Inclusion body myositis Hypersensitivity pneumonitis Infantile apnoea Oesophageal achalasia Choroidal dystrophy More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Diagnostics Short-bowel syndrome – Basic Information Medulloblastoma recurrent – Treatment Primary immunodeficiency syndrome – Diagnostics Lymphangioma – Life with Disease Systemic mastocytosis – Trials in Disease Prolymphocytic leukaemia Fragile X syndrome – Basic Information IgA nephropathy Short-bowel syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Efpegerglucagon Abc-31-116 Rtx001 Ursodoxicoltaurine Vafidemstat ZILUCOPLAN ACETYLCARNITINE HYDROCHLORIDE Syn321 Propafenone Hydrochloride Cortisone Anakinra Mk-4830 Guanfacine Umeclidinium Bromide NALDEMEDINE Rezpegaldesleukin Nadunolimab Paclitaxel Bt-001 Ropivacaine Hydrochloride More therapies…

    Learn about Your Condition

    Laryngeal cancer stage I Diabetic neuropathy Haemodynamic instability Acute hepatic failure Spinal osteoarthritis Gastrooesophageal cancer Necrotising myositis Dizziness Gastric cancer Epidermolysis bullosa Drug eruption Migraine without aura Follicular lymphoma stage III Venous thrombosis Acute coronary syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Semaglutide for Treating Prediabetes in Women with Previous Gestational Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    Investigated Drugs:
    • Semaglutide
    Belgium

  • Study on Meniere’s Disease: Comparing Methylprednisolone and Placebo for Patients with Unilateral Meniere’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Deafness
    • Dizziness
    • Ear discomfort
    Investigated Drugs:
    • Gentamicin
    • Metoclopramide
    • Triamcinolone Acetonide
    The Netherlands

  • Study on the Effectiveness and Safety of Indacaterol Acetate/Mometasone Furoate vs. Budesonide for Children Aged 6-11 with Asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Budesonide
    • Indacaterol Acetate
    • Mometasone Furoate
    Austria Bulgaria Czechia Greece Hungary Italy +3

  • Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    • Pembrolizumab
    Belgium Czechia France Germany Greece Ireland +4

  • Study on Valaciclovir for Treating Advanced Gum Disease in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Periodontitis
    Investigated Drugs:
    • Valaciclovir
    • Cellulose, Microcrystalline
    France

  • Study Comparing Conventional Radiotherapy and PSMA-PET/CT Targeted Treatment with 18F-PSMA-1007 and Gozetotide for Prostate Cancer Recurrence After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    Investigated Drugs:
    • Gozetotide
    Sweden
Previous Page
1 … 587 588 589 590 591 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!